ReviewNature reviews. Clinical oncology2023
TAM family kinases as therapeutic targets at the interface of cancer and immunity.
Deborah DeRyckere et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
61 papers cite itlatest 60 shown
this papertrialcites it